13G Filing: Visium Asset Management Has Nearly Doubled Its Stake in La Jolla Pharmaceutical Co (LJPC)

Page 7 of 12

Page 7 of 12 SEC Filing


CUSIP No. 503459604 Page
7
of 12Pages
Item 3 If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);*
¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
x A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);*
¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).
* VAM is an investment adviser as described above and JG Asset and Gottlieb are each a parent holding company or control person as described above.
Item 4 Ownership:

VBMF

(a) Amount Beneficially Owned:

1,182,013

(b) Percent of Class:

6.5%

(c) Number of Shares as to which person has:
(i) sole power to vote or to direct vote:

None

Page 7 of 12 Pages

Follow La Jolla Pharmaceutical Co (NASDAQ:LJPC)

Page 7 of 12